Global
Protein
Drugs Market is expected to grow at a significant CAGR in the
upcoming years as the scope and its applications are increasing across the
globe. The factors that propel the growth of the industry include increasing
demand, rapid urbanization & industrialization, and product development
& technological innovations.
In
addition, key factors such as rise in geriatric population, growing prevalence
of disorders, increasing research undertakings, and awareness among people
significantly contribute to the growth of Protein Drugs Market. On the other
hand, there are also factors that may hamper the growth of the market such as
high cost of protein drugs.
Protein
Drugs Market is classified on the basis of product type, applications,
distribution channel and geography. Protein Drugs Industry is segmented by
product type as antibody drugs, blood products, enzymes, peptide hormones, and
others. Protein Drugs Industry is classified on applications as AIDS, cancer,
diabetes, hepatitis, and others. The market is segmented by distribution
channel as online stores, specialty stores and others. Protein Drugs Market is
classified on the basis of geography as North America, Latin America, Western
Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.
The
North American region consists of the U.S., and Canada. Latin America region
consists of Mexico and Brazil. The Western European region consists of Germany,
Italy, France, England and Spain. The Eastern European region consists of
Poland and Russia. Asia Pacific region consists of China, India, ASEAN,
Australia & New Zealand. The Middle East and African region consists of
GCC, South Africa and North Africa. By geography, North America is projected to
register a major share of the Protein Drugs Market. The key factors that
attribute to the growth of this region include increasing demand, favorable
reimbursement policies, rising prevalence of disorders, affordability and
growing R&D undertakings. On the other hand, Asia Pacific is expected to
show high growth rates in the Protein Drugs Market.
Some
of the key players that fuel the growth of the Protein Drugs Market include
Abbott Laboratories, Amgen, Bristol-Myers Squibb, Biogen Idec, Dendreon
Corporation, Genentech, Eli Lilly, Johnson & Johnson, Novo Nordisk, UCB
Group, Schering-Plough Corporation, and others. The key players are focusing on
inorganic growth to sustain themselves amidst fierce competition. As such,
mergers, acquisitions, and joint ventures are the need of the hour.
Market Segment:
Geographically, this report split global
into several key Regions, with sales (K Pcs), revenue (Million USD), market
share and growth rate of Protein Drugs for these regions, from 2012 to 2022
(forecast), covering
United
States
China
Europe
Japan
Southeast
Asia
India
Global Protein Drugs market competition
by top manufacturers/players, with Protein Drugs sales volume, Price (USD/Pcs),
revenue (Million USD) and market share for each manufacturer/player; the top
players including
•
Eli Lilly
•
Abbott Laboratories
•
UCB Group
•
Schering-Plough Corporation
•
Genentech
•
Johnson?Johnson
•
Bristol-Myers Squibb
•
Novo Nordisk
•
Biogen Idec
•
Dendreon Corporatio
Comments
Post a Comment